5 Best Cheap Stocks Under $10 to Buy in April

1. Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

PE Ratio: 1.82

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) is among the best cheap stocks to buy.

TheFly reported on March 17 that ATRA filed a prospectus to register the potential resale of up to 400,000 common shares by HCR Molag Fund, L.P. These shares are issuable through the exercise of a warrant previously granted to HCR under an amended purchase agreement. The registration ensures compliance with the warrant’s terms but does not guarantee that HCR will sell any shares. Proceeds from any sale will go to the selling stockholder, not ATRA. Shares may be sold publicly or privately at prevailing or negotiated market prices, with HCR responsible for associated selling costs while ATRA covers registration-related expenses.

Separately, in a regulatory update, on March 12, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) announced that a Type A meeting with the U.S. Food and Drug Administration has been arranged to address the complete response letter issued for the biologics license application of tabelecleucel, managed by partner Pierre Fabre Pharmaceuticals. ATRA is supporting Pierre Fabre in engaging with the FDA to collaboratively resolve the concerns outlined in the CRL. The meeting aims to discuss the additional efficacy data collected since the original submission and to facilitate a potential resubmission of the BLA, ensuring regulatory compliance and advancing the review process for tabelecleucel.

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) is a clinical‑stage biopharmaceutical company developing off‑the‑shelf T‑cell immunotherapies for cancer and autoimmune diseases to improve patient outcomes.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.